基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 2,965.65
成立日期: 05/02/2001
 
分析
市值分佈:
85.95%
大市值
10.00%
中市值
3.13%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:09) 總持有投資項目: 247  
0%
 
100%
     10大 (45.54%)
代號 名稱 佔比% 持有日期
GPCRStructure Therapeutics0.2029/04/2026
BCRXBioCryst Pharmaceuticals0.1929/04/2026
NAMSNewAmsterdam Pharma Company NV0.1929/04/2026
SRPTSarepta Therapeutics0.1929/04/2026
TNGXTango Therapeutics0.1929/04/2026
VERAVera Therapeutics0.1929/04/2026
ADPTAdaptive Biotechnologies Corp0.1929/04/2026
RCUSArcus Biosciences0.1927/04/2026
ZYMEZymeworks0.1929/04/2026
DFTXDefinium Therapeutics Inc0.1829/04/2026
IRONDisc Medicine0.1829/04/2026
AUPHAurinia Pharmaceuticals0.1827/04/2026
ELVNEnliven Therapeutics0.1729/04/2026
DICE--0.1731/07/2023
SNDXSyndax Pharmaceuticals0.1629/04/2026
GRALGRAIL Inc.0.1629/04/2026
ZLABZai Lab Limited0.1629/04/2026
ERASErasca0.1629/04/2026
VCELVericel Corp0.1629/04/2026
RLAYRelay Therapeutics0.1529/04/2026
  1    2    3    4   5    6    7    8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.